Takeda’s Bid For Millennium May Face Several Hurdles – Pharma Analyst

TOKYO - Several factors could still prevent Japan's top drug company Takeda from acquiring U.S.-based Millennium Pharmaceuticals, a pharmaceutical analyst said in an interview with PharmAsia News

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip